Ferroptosis: A Promising Therapeutic Target for Neonatal Hypoxic-Ischemic Brain Injury

Eric S Peeples1,2,3, Thiago C Genaro-Mattos3,4

  • 1Department of Pediatrics, University of Nebraska Medical Center, Omaha, NE 68198, USA.

Insights

Ferroptosis, a cell death pathway involving lipid peroxidation, is increasingly recognized as a key factor in neonatal hypoxic-ischemic brain injury (HIBI). Understanding ferroptosis pathways and interventions is crucial for treating HIBI.

Area of Science:

  • Neuroscience
  • Cell Biology
  • Pathology

Background:

  • Ferroptosis is programmed cell death driven by phospholipid peroxidation.
  • It is implicated in diseases involving ischemic-reperfusion injury.
  • Ferroptosis is a potential key mechanism in neonatal hypoxic-ischemic brain injury (HIBI).

Purpose of the Study:

  • To review ferroptotic pathways in the context of neonatal HIBI.
  • To explore the activation mechanisms of ferroptosis following HIBI.
  • To identify interventions that may reduce ferroptotic cell death in HIBI.

Main Methods:

  • Literature review of ferroptosis and HIBI.
  • Analysis of cellular pathways involved in ferroptosis.
  • Examination of current and investigational therapeutic strategies.

Main Results:

  • Ferroptosis pathways can be activated by HIBI.
  • Specific molecular mechanisms link HIBI to ferroptosis.
  • Several interventions show potential to mitigate ferroptosis in HIBI models.

Conclusions:

  • Ferroptosis is a significant contributor to neonatal brain injury.
  • Targeting ferroptosis pathways offers a promising therapeutic avenue for HIBI.
  • Further research is needed to translate these findings into clinical practice.